# OnCo record ctdna-lymphoma-monitoring (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/ctdna-lymphoma-monitoring/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "ctdna-lymphoma-monitoring" ;
  schema:name "ctDNA monitoring in lymphoma (PhasED-seq, clonoSEQ)"@en ;
  schema:description "A blood test that tracks lymphoma DNA far below what a PET scan can see, so doctors can tell early who is cured and who will relapse."@en ;
  schema:url <https://onco.cc/technologies/ctdna-lymphoma-monitoring/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.2018.78.5246>, <https://doi.org/10.1038/s41587-021-00981-w>, <https://doi.org/10.1126/scitranslmed.aai8545>, <https://doi.org/10.1038/s41587-021-00981-w> ;
  onco:status "emerging" ;
  onco:cancers <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/diagnostics/> ;
  onco:technologies <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/technologies/mrd-testing/> ;
  onco:companies <https://onco.cc/companies/foresight-diagnostics/> ;
  onco:terms <https://onco.cc/terms/mrd/>, <https://onco.cc/terms/ctdna/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-kurtz-j-clin-oncol/>, <https://onco.cc/key-papers/paper-kurtz-nat-biotechnol/> .